Chemoinformaics analysis of NOMILINIC-ACID-17-O-BETA-D-GLUCOSIDE
| Molecular Weight | 712.742 | nRot | 11 |
| Heavy Atom Molecular Weight | 664.358 | nRig | 29 |
| Exact Molecular Weight | 712.294 | nRing | 5 |
| Solubility: LogS | -2.75 | nHRing | 3 |
| Solubility: LogP | 0.195 | No. of Aliphatic Rings | 4 |
| Acid Count | 2 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 98 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 50 | No. of Aromatic Carbocycles | 0 |
| nHetero | 16 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 48 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 34 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 5 |
| No. of Oxygen atom | 16 | No. of Arom Bond | 5 |
| nHA | 14 | APOL | 101.618 |
| nHD | 7 | BPOL | 60.3059 |
| QED | 0.122 |
| Synth | 6.429 |
| Natural Product Likeliness | 2.614 |
| NR-PPAR-gamma | 0.518 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.941 |
| HIA | 0.985 |
| CACO-2 | -6.282 |
| MDCK | 0.000331881 |
| BBB | 0.084 |
| PPB | 0.535832 |
| VDSS | 0.287 |
| FU | 0.327019 |
| CYP1A2-inh | 0 |
| CYP1A2-sub | 0.029 |
| CYP2c19-inh | 0.002 |
| CYP2c19-sub | 0.058 |
| CYP2c9-inh | 0.001 |
| CYP2c9-sub | 0.333 |
| CYP2d6-inh | 0.01 |
| CYP2d6-sub | 0.07 |
| CYP3a4-inh | 0.014 |
| CYP3a4-sub | 0.012 |
| CL | 1.635 |
| T12 | 0.607 |
| hERG | 0.001 |
| Ames | 0.132 |
| ROA | 0.976 |
| SkinSen | 0.006 |
| Carcinogencity | 0.642 |
| EI | 0.005 |
| Respiratory | 0.954 |
| NR-Aromatase | 0.023 |
| Antiviral | Yes |
| Prediction | 0.841297 |